Akeso Eulerpool News

Akeso Aktie News

Akeso wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Akeso News stellen wir hier zusammen.

• 5. Juni ·

  Yahoo
  Akeso gains NMPA approval for cadonilimab to treat cervical cancer
• 5. Juni ·

  Yahoo
  Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab
• 3. Juni ·

  SeekingAlpha
  Explaining Summit's Fall Despite Positive Data In EGFR-Positive Lung Cancer
• 2. Juni ·

  Yahoo
  Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal
• 9. Mai ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 8. Mai ·

  SeekingAlpha
  BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit
• 2. Mai ·

  Yahoo
  Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil
• 26. April ·

  SeekingAlpha
  Summit Therapeutics: New Ivonescimab Data Raise Concerns
• 20. April ·

  SeekingAlpha
  Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain
• 21. Februar ·

  Yahoo
  Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer